ANALYZER, SENTORR BLOOD GAS

FDA 510(k)

FDA Class 2 ·Anesthesiology

ISCALERT SENSOR SYSTEM

FDA 510(k)

FDA Class 2 ·Anesthesiology

POINT-OF-CARE ARTERIAL BLOOD GAS MONITORING SYSTEM

FDA 510(k)

FDA Class 2 ·Anesthesiology

POINT-OF-CARE BLOOD GAS MONITOR SYSTEM

FDA 510(k)

FDA Class 2 ·Anesthesiology

MEDTRONIC INTRAVASCULAR BLOOD GAS MONITORING

FDA 510(k)

FDA Class 2 ·Anesthesiology

OLYMPUS CRITICAL CARE MONITORING SYSTEM

FDA 510(k)

FDA Class 2 ·Anesthesiology

TRENDCARE CALIBRATOR MODEL SCU 7007

FDA 510(k)

FDA Class 2 ·Anesthesiology

OXYGEN ANALYZER 110

FDA 510(k)

FDA Class 2 ·Anesthesiology

SENSICATH POINT-OF-CARE BLOOD GAS MONITORING SYSTE

FDA 510(k)

FDA Class 2 ·Anesthesiology

BIOTOP HOOKSAFE SAFETY SYRINGE, MODELS 0.5CC/ML, 1CC/ML, 3CC/ML, 5CC/ML AND 10CC/ML

FDA 510(k)

FDA Class 2 ·General Hospital

Sharps Needle Destruction Device

FDA Pre-Market Approval

FDA Class 2 ·THE DISINTEGRATOR PLUS LANCE/INSULIN NEEDLE DESTRUCTON DEVICE

EXSUDEX WOUND DRAINAGE PUMP

FDA 510(k)

FDA Class 2 ·General, Plastic Surgery

FINAPRES NOVA NONINVASIVE HEMODYNAMIC MONITOR

FDA 510(k)

FDA Class 2 ·Cardiovascular

Finapres Nova Noninvasive Hemodynamic Monitor

FDA 510(k)

FDA Class 2 ·Cardiovascular

Sharps Needle Destruction Device

FDA Pre-Market Approval

FDA Class 2 ·DISINTEGRATOR PRO NEEDLE DESTRUCTION DEVICE

Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment

FDA classification

FDA Class 2 ·Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment

CAREO SAFETY SYRINGE 1CC/ML, MODELS CA0106-C,CA0196-C,CA0186-C,CA0107-C,CA0197-C,CA0187-C,CA0104-C,CA0194-C,CA0184-C,

FDA 510(k)

FDA Class 2 ·General Hospital

System, Imaging, Optical Coherence Tomography (Oct)

FDA classification

FDA Class 2 ·System, Imaging, Optical Coherence Tomography (Oct)

Analyzer, Gas, Carbon-Dioxide, Partial Pressure, Blood-Phase, Indwelling

FDA classification

FDA Class 2 ·Analyzer, Gas, Carbon-Dioxide, Partial Pressure, Blood-Phase, Indwelling

Des-Gamma-Carboxy-Prothrombin (Dcp), Risk Assessment, Hepatocellular Carcinoma

FDA classification

FDA Class 2 ·Des-Gamma-Carboxy-Prothrombin (Dcp), Risk Assessment, Hepatocellular Carcinoma